A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia

Conditions:   Gestational Trophoblastic Disease;   Gestational Trophoblastic Neoplasia;   Gestational Trophoblastic Tumor, Recurrent Intervention:   Drug: Pembrolizumab Sponsors:   Imperial College London;   Cancer Research UK Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials